Literature DB >> 8970974

Differential transactivation of the intercellular adhesion molecule 1 gene promoter by Tax1 and Tax2 of human T-cell leukemia viruses.

Y Tanaka1, M Hayashi, S Takagi, O Yoshie.   

Abstract

Previously, we showed that surface expression of intercellular adhesion molecule 1 (ICAM-1) was strongly upregulated in T cells carrying proviral human T-cell leukemia virus type 1 (HTLV-1) and that the viral transactivator protein Tax1 was capable of inducing the ICAM-1 gene. To determine the responsive elements in the human ICAM-1 gene promoter, a reporter construct in which the 5'-flanking 4.4-kb region of the ICAM-1 gene was linked to the promoterless chloramphenicol acetyltransferase (CAT) gene was cotransfected with expression vectors for Tax1 and Tax2, both of which were separately confirmed to be potent transactivators of the HTLV-1 long terminal repeat (LTR). Tax1 strongly activated the ICAM-1 promoter in all the cell lines tested: three T-cell lines (Jurkat, MOLT-4, and CEM), one monocytoid cell line (U937), and HeLa. Unexpectedly, Tax2 activated the ICAM-1 promoter only in HeLa. By deletion and mutation analyses of the 1.3-kb 5'-flanking region, we found that Tax1 transactivated the ICAM-1 promoter mainly via a cyclic AMP-responsive element (CRE)-like site at -630 to -624 in the Jurkat T-cell line and via an NF-kappaB site at -185 to -177 and an SP-1 site at -59 to -54 in HeLa. On the other hand, Tax2 was totally inactive on the ICAM-1 promoter in Jurkat but transactivated the promoter via the NF-kappaB site at -185 to -177 in HeLa. Gel mobility shift assays demonstrated proteins specifically binding to the CRE-like site at -630 to -624 in Tax1-expressing T-cell lines. Stable expression of Tax1 but not Tax2 in Jurkat subclones enhanced the surface expression of ICAM-1. The differential ability of Tax1 and Tax2 in transactivation of the ICAM-1 gene may be related to the differential pathogenicity of HTLV-1 and HTLV-2.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8970974      PMCID: PMC190942     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  65 in total

1.  Adult T-cell leukemia: clinical and hematologic features of 16 cases.

Authors:  T Uchiyama; J Yodoi; K Sagawa; K Takatsuki; H Uchino
Journal:  Blood       Date:  1977-09       Impact factor: 22.113

2.  Detection of mRNA for the tax1/rex1 gene of human T-cell leukemia virus type I in fresh peripheral blood mononuclear cells of adult T-cell leukemia patients and viral carriers by using the polymerase chain reaction.

Authors:  T Kinoshita; M Shimoyama; K Tobinai; M Ito; S Ito; S Ikeda; K Tajima; K Shimotohno; T Sugimura
Journal:  Proc Natl Acad Sci U S A       Date:  1989-07       Impact factor: 11.205

3.  Activation of endogenous c-fos proto-oncogene expression by human T-cell leukemia virus type I-encoded p40tax protein in the human T-cell line, Jurkat.

Authors:  K Nagata; K Ohtani; M Nakamura; K Sugamura
Journal:  J Virol       Date:  1989-08       Impact factor: 5.103

4.  Cell line-dependent response of the enhancer element of simian virus 40 to transactivator p40tax encoded by human T-cell leukemia virus type I.

Authors:  M Nakamura; M Niki; K Nagata; K Ohtani; S Saito; Y Hinuma; K Sugamura
Journal:  J Biol Chem       Date:  1989-12-05       Impact factor: 5.157

5.  Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei.

Authors:  J D Dignam; R M Lebovitz; R G Roeder
Journal:  Nucleic Acids Res       Date:  1983-03-11       Impact factor: 16.971

6.  A new subtype of human T-cell leukemia virus (HTLV-II) associated with a T-cell variant of hairy cell leukemia.

Authors:  V S Kalyanaraman; M G Sarngadharan; M Robert-Guroff; I Miyoshi; D Golde; R C Gallo
Journal:  Science       Date:  1982-11-05       Impact factor: 47.728

7.  Adult T-cell leukemia: antigen in an ATL cell line and detection of antibodies to the antigen in human sera.

Authors:  Y Hinuma; K Nagata; M Hanaoka; M Nakai; T Matsumoto; K I Kinoshita; S Shirakawa; I Miyoshi
Journal:  Proc Natl Acad Sci U S A       Date:  1981-10       Impact factor: 11.205

8.  Human adult T-cell leukemia virus: complete nucleotide sequence of the provirus genome integrated in leukemia cell DNA.

Authors:  M Seiki; S Hattori; Y Hirayama; M Yoshida
Journal:  Proc Natl Acad Sci U S A       Date:  1983-06       Impact factor: 11.205

Review 9.  The CD2-LFA-3 and LFA-1-ICAM pathways: relevance to T-cell recognition.

Authors:  M W Makgoba; M E Sanders; S Shaw
Journal:  Immunol Today       Date:  1989-12

10.  Detection of human T lymphotrophic virus type I (HTLV-I) proviral DNA and analysis of T cell receptor V beta CDR3 sequences in spinal cord lesions of HTLV-I-associated myelopathy/tropical spastic paraparesis.

Authors:  H Hara; M Morita; T Iwaki; T Hatae; Y Itoyama; T Kitamoto; S Akizuki; I Goto; T Watanabe
Journal:  J Exp Med       Date:  1994-09-01       Impact factor: 14.307

View more
  19 in total

1.  Expressions of ICAM-1 and its mRNA in sera and tissues of patients with hepatocellular carcinoma.

Authors:  J Xu; M H Mei; S E Zeng; Q F Shi; Y M Liu; L L Qin
Journal:  World J Gastroenterol       Date:  2001-02       Impact factor: 5.742

2.  Transcriptional activation of the vascular cell adhesion molecule-1 gene in T lymphocytes expressing human T-cell leukemia virus type 1 Tax protein.

Authors:  H Valentin; I Lemasson; S Hamaia; H Cassé; S König; C Devaux; L Gazzolo
Journal:  J Virol       Date:  1997-11       Impact factor: 5.103

3.  RANK-c attenuates aggressive properties of ER-negative breast cancer by inhibiting NF-κB activation and EGFR signaling.

Authors:  Chaido Sirinian; Anastasios D Papanastasiou; Michail Schizas; Magda Spella; Georgios T Stathopoulos; Maria Repanti; Ioannis K Zarkadis; Tari A King; Haralabos P Kalofonos
Journal:  Oncogene       Date:  2018-05-29       Impact factor: 9.867

4.  Site-specific phosphorylation of the p65 protein subunit mediates selective gene expression by differential NF-κB and RNA polymerase II promoter recruitment.

Authors:  Karin Hochrainer; Gianfranco Racchumi; Josef Anrather
Journal:  J Biol Chem       Date:  2012-10-25       Impact factor: 5.157

5.  Recombinant human T-cell leukemia virus types 1 and 2 Tax proteins induce high levels of CC-chemokines and downregulate CCR5 in human peripheral blood mononuclear cells.

Authors:  Christy S Barrios; Muna Abuerreish; Michael D Lairmore; Laura Castillo; Chou-Zen Giam; Mark A Beilke
Journal:  Viral Immunol       Date:  2011-11-23       Impact factor: 2.257

6.  Inhibition of human T cell leukemia virus type 2 replication by the suppressive action of class II transactivator and nuclear factor Y.

Authors:  Giovanna Tosi; Elisabetta Pilotti; Lorenzo Mortara; Andrea De Lerma Barbaro; Claudio Casoli; Roberto S Accolla
Journal:  Proc Natl Acad Sci U S A       Date:  2006-08-14       Impact factor: 11.205

7.  Differences in the ability of human T-cell lymphotropic virus type 1 (HTLV-1) and HTLV-2 tax to inhibit p53 function.

Authors:  R Mahieux; C A Pise-Masison; P F Lambert; C Nicot; L De Marchis; A Gessain; P Green; W Hall; J N Brady
Journal:  J Virol       Date:  2000-08       Impact factor: 5.103

8.  Human T-cell leukemia virus type 2 produces a spliced antisense transcript encoding a protein that lacks a classic bZIP domain but still inhibits Tax2-mediated transcription.

Authors:  Marilène Halin; Estelle Douceron; Isabelle Clerc; Chloé Journo; Nga Ling Ko; Sébastien Landry; Edward L Murphy; Antoine Gessain; Isabelle Lemasson; Jean-Michel Mesnard; Benoît Barbeau; Renaud Mahieux
Journal:  Blood       Date:  2009-07-14       Impact factor: 22.113

9.  Human T-cell leukemia virus type 1 (HTLV-1) and HTLV-2 tax oncoproteins modulate cell cycle progression and apoptosis.

Authors:  Michelle Sieburg; Adam Tripp; Jung-Woo Ma; Gerold Feuer
Journal:  J Virol       Date:  2004-10       Impact factor: 5.103

10.  The HTLV-1 tax protein cooperates with phosphorylated CREB, TORC2 and p300 to activate CRE-dependent cyclin D1 transcription.

Authors:  Y-M Kim; T R Geiger; D I Egan; N Sharma; J K Nyborg
Journal:  Oncogene       Date:  2010-01-25       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.